Business
TechCare Signs its First European Distribution Agreement for Novokid Lice Treatment Device, with MWMedical B.V. in the Netherlands
TechCare Signs its First European Distribution Agreement for Novokid Lice Treatment Device, with MWMedical B.V. in the Netherlands.
About this update from Citrine Global Corp.
[{"type":"text","content":"\n\n\n\nTechCare Signs its First European Distribution Agreement for Novokid Lice Treatment Device, with MWMedical B.V. in the Netherlands\n\n\n\n\n\nTechCare Signs its First European Distribution Agreement for Novokid Lice Treatment Device, with MWMedical B.V. in the Netherlands\nPR Newswire\nNEW YORK, January 23, 2018\n\n\n\nNEW YORK, January 23, 2018 /PRNewswire/ --\n\nTechCare Corp. (OTCQB: TECR), a technology company with a revolutionary delivery platform that uses vapor technology for natural health, wellness and beauty treatments, today announced it has signed its first distribution agreement with MWMedical B.V., a leading distributor of medical devices in the Netherlands, for TechCare's Novokid lice treatment device, which addresses a $1.8 billion market globally, and a European market estimated to exceed $500 million.\n\nThe multi-year agreement grants the distributor exclusive distribution rights in the Netherlands in consideration of minimum purchase commitments. The distributor has already placed its first order of Novokid's products, 2,500 kits, which will be available in the Netherlands beginning                           in mid-February.\n\nThe Netherlands represents the first success for TechCare among 28 European countries that TechCare is able to sell to following the receipt of CE Approval in August of last year. As the Netherlands is one of the most densely populated countries in the world, with 17.04 million people living in close proximity, lice management is very important in this country.\n\nTechCare is laser focused on expanding to the remaining 27 countries, as well as to gain repeat and increased orders from its Dutch partner.\n\nAccording to Zvi Yemini, Chairman of TechCare Corp., \"TechCare is delighted to announce its first agreement for Novokid with MWMedical to provide TechCare's leading technology with the broad representation of this organization in Netherlands. We are proud that after a wide-ranging evaluation, MWMedical has selected TechCare's technology. Beginning in February, the Dutch market will now have wide access to the superior Novokid lice treatment device.\"\n\nMaarten Wijsmuller, CEO of MWMedical B.V. commented, \"We were very attracted to the Novokid Lice Treatment for many reasons. First, Novokid is remarkably conven...